The focus of Raisio’s renewed strategy 2017 - 2022 is on wellbeing and sustainable growth. The core of Raisio’s strategy consists of plant-based, healthy and responsible branded products that meet the needs of consumers and customers. In line with the renewed strategy, Raisio continues to invest in brands, product concepts, sales&marketing and to streamline its operations.
Raisio is known for its innovations, of which cholesterol-lowering Benecol is one good example and Benemilk, with its ability to increase milk yield and improve contents of milk, another. Raisio's top innovations and numerous inventions are proof of the company's ability to develop methods and products to solve global problems and profitability issues concerning the agri-food sector. Moreover, Raisio was the first company in the world to use water and carbon footprint labels on consumer products.
Raisio's operations are divided into two divisions: Brands and Raisioagro. The Brands Division includes the following businesses: Benecol, Healthy Food, Confectionery and Benemilk. Benecol business includes the Benecol product ingredient sales to licensing partners globally and Benecol consumer product sales in Raisio’s home markets. Home markets for Raisio’s Benecol consumer products include the UK, Poland, Finland, Ireland, Belgium and Hong Kong. Healthy Food business' markets are Northern and Eastern Europe. Confectionery includes the businesses in the UK and Czech Republic. Benemilk includes the international commercialisation and protection of the innovation. Raisioagro Division includes cattle and fish feeds, farming supplies and grain trade.
Raisio's most recognised food brands are Benecol, Elovena, Sunnuntai, Nordic, Fox's, Poppets and Juicee Gummee. Raisioagro's most recognised feed brands are Benemilk, Hercules and Maituri.
Raisio plc is a Finnish company established in 1939, whose shares are listed on Nasdaq Helsinki Ltd. The company has some 40,000 shareholders. It employs some 1,400 people and operates in 12 countries. Group's net sales in 2016 were EUR 436 million and comparable EBIT was EUR 51 million.